Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 1
1962 1
1963 5
1964 22
1965 262
1966 574
1967 752
1968 830
1969 962
1970 971
1971 1129
1972 1146
1973 1224
1974 1193
1975 1018
1976 997
1977 1010
1978 1061
1979 1091
1980 1049
1981 1129
1982 1148
1983 1201
1984 1315
1985 1424
1986 1363
1987 1508
1988 1364
1989 1648
1990 1863
1991 1796
1992 1936
1993 1872
1994 1872
1995 1761
1996 1875
1997 1760
1998 1945
1999 2044
2000 2196
2001 2373
2002 2800
2003 3016
2004 3029
2005 3435
2006 3630
2007 3951
2008 4240
2009 4580
2010 4826
2011 5208
2012 5254
2013 5506
2014 5612
2015 5567
2016 5454
2017 5413
2018 5322
2019 5541
2020 6342
2021 6617
2022 6079
2023 5604
2024 1637

Text availability

Article attribute

Article type

Publication date

Search Results

145,343 results

Results by year

Filters applied: . Clear all
Page 1
Rare bleeding disorders.
Peyvandi F, Bolton-Maggs PH, Batorova A, De Moerloose P. Peyvandi F, et al. Haemophilia. 2012 Jul;18 Suppl 4:148-53. doi: 10.1111/j.1365-2516.2012.02841.x. Haemophilia. 2012. PMID: 22726099 Review.
Anticoagulation in Patients with Platelet Disorders.
Zaninetti C, Thiele T. Zaninetti C, et al. Hamostaseologie. 2021 Apr;41(2):112-119. doi: 10.1055/a-1344-7279. Epub 2021 Apr 15. Hamostaseologie. 2021. PMID: 33860519 Review.
Novel pharmacotherapy for drug-induced immune hemolytic anemia.
Barcellini W, Fattizzo B. Barcellini W, et al. Expert Opin Pharmacother. 2023 Sep-Dec;24(18):1927-1931. doi: 10.1080/14656566.2023.2291075. Epub 2024 Jan 5. Expert Opin Pharmacother. 2023. PMID: 38037866 No abstract available.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Lanino L, Restuccia F, Perego A, Ubezio M, Fattizzo B, Riva M, Consagra A, Musto P, Cilloni D, Oliva EN, Palmieri R, Poloni A, Califano C, Capodanno I, Itri F, Elena C, Fozza C, Pane F, Pelizzari AM, Breccia M, Di Bassiano F, Crisà E, Ferrero D, Giai V, Barraco D, Vaccarino A, Griguolo D, Minetto P, Quintini M, Paolini S, Sanpaolo G, Sessa M, Bocchia M, Di Renzo N, Diral E, Leuzzi L, Genua A, Guarini A, Molteni A, Nicolino B, Occhini U, Rivoli G, Bono R, Calvisi A, Castelli A, Di Bona E, Di Veroli A, Ferrara F, Fianchi L, Galimberti S, Grimaldi D, Marchetti M, Norata M, Frigeni M, Sancetta R, Selleri C, Tanasi I, Tosi P, Turrini M, Giordano L, Finelli C, Pasini P, Naldi I, Santini V, Della Porta MG; Fondazione Italiana Sindromi Mielodisplastiche (FISiM) Clinical network (https://www.fisimematologia.it/). Lanino L, et al. Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24. Am J Hematol. 2023. PMID: 37222267 No abstract available.
145,343 results
You have reached the last available page of results. Please see the User Guide for more information.